What Researchers Did
Researchers conducted a systematic review and meta-analysis of seven randomized controlled trials to evaluate the efficacy and safety of hyperbaric oxygen therapy (HBOT) for diabetic foot ulcers (DFUs).
What They Found
Hyperbaric oxygen therapy significantly improved the complete healing rates of diabetic foot ulcers, with a risk ratio of 3.59 (95% CI: 1.56-8.29, p < 0.001). However, HBOT did not show a statistically significant impact on major or minor amputation rates.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers may benefit from hyperbaric oxygen therapy as an additional treatment to promote complete ulcer healing. While it may help heal ulcers, patients should understand that this therapy was not found to significantly reduce the risk of major or minor amputations.
Canadian Relevance
This study did not include any Canadian participants or data, so its direct relevance to the Canadian healthcare context is not explicitly established.
Study Limitations
The findings are based on a limited number of included studies, and the generalizability may depend on the specific characteristics of those trials.